Shinhan Invest

Phantom AI, Inc. specializes in developing advanced driver-assistance systems (ADAS) powered by artificial intelligence and sensors for autonomous vehicles. The company offers a range of products, including PhantomVision, a deep learning-based computer vision solution that supports Euro NCAP compliant ADAS features, enabling the detection of vehicles, pedestrians, bicyclists, and traffic signals. Additionally, PhantomFusion provides a platform-independent sensor fusion and object tracking system that integrates data from various sensors to create a comprehensive environmental model. PhantomDrive enhances vehicle control by predicting the motion of detected objects, contributing to safer driving experiences. Founded in 2016 and based in Burlingame, California, Phantom AI aims to make advanced driving technologies accessible and cost-effective for car manufacturers and suppliers, ultimately enhancing road safety and driving enjoyment.

NEXEON Limited operates as a battery materials and licensing company that develops silicon anodes for lithium-ion batteries. It offers silicon anode technology solutions for various applications, including consumer electronic, electronic vehicle, sustainable energy, aerospace, medical, and defense industries in the United Kingdom and internationally. The company was founded in 2006 and is based in Abingdon, United Kingdom with an additional office in Yokohama, Japan.

KB-Element Co., Ltd. is a South Korean company established in 2016, specializing in the development and manufacturing of graphene powder and carbon nanotube (CNT) coating solutions. The company produces a range of products including anti-static agents, conductive pastes, heat-releasing materials, and large-area coating equipment. Its materials are designed for use in semiconductor and display applications, addressing issues related to harmful electromagnetic waves and heat generation in electronic devices, which are increasingly challenged by the miniaturization of electronic components. Through its innovative solutions, KB-Element aims to enhance the performance and reliability of electronic devices.

Cerecin is a healthcare company that develops novel evidence-based therapeutics and products that aim to help people. We develop novel evidence-based therapeutics and products that aim to help millions of people. These solutions are designed to target conditions ranging from memory impairment to Alzheimer’s disease and other devastating neurological diseases.

AffyXell was established in January 2020 by Avacta and Daewoong as a joint venture to develop novel mesenchymal stem cell (MSC) therapies.

MakinaRocks Co., Ltd. is a South Korean company, established in December 2017 and headquartered in Seoul, that specializes in developing software solutions aimed at enhancing manufacturing processes through industrial machine intelligence. The company focuses on analyzing sensor data from manufacturing equipment using machine learning techniques to predict equipment malfunctions and quality issues, thereby improving productivity and product quality. MakinaRocks provides its solutions to various high-tech sectors, including semiconductor manufacturing, automotive, steel production, and specialty chemicals. Its offerings include anomaly detection models and intelligent control algorithms that help manufacturers implement predictive maintenance and optimize operations.

Lunit Inc. is a South Korean company that specializes in developing advanced algorithms for medical image analysis and general object detection using machine learning technology. The firm focuses on areas such as digital chest X-ray, digital mammography, digital pathology, and fundus photography. By leveraging cutting-edge deep learning techniques, Lunit aims to assist physicians in making accurate and efficient clinical decisions. The company has demonstrated its expertise in image recognition, having ranked among the top five in the ImageNet Challenge, a prominent competition in the field. Lunit's technology is notable for its ability to utilize weakly labeled data, enhancing its pattern recognition capabilities. Supported by significant venture capital investments, Lunit is actively engaged in large-scale research collaborations with major university hospitals in South Korea, reflecting its strong reception within the medical community.

LISCure Biosciences is a developer of bacteria-mediated immunotherapy designed to treat tumors as well as degenerative neurological, autoimmune and metabolic diseases. The company currently has seven pipelines of medicine and two pipelines of health-functioning food and is considering the introduction of two more pipes.

Lemon Healthcare is a mobile healthcare service that aims to streamline interactions between patients and medical institutions. The company has developed a software platform that facilitates the entire hospital process, from appointment scheduling to prescription management. It offers features such as appointment reminders and one-click payment options, enhancing convenience for users. Additionally, the platform allows prescriptions to be sent directly to pharmacies and manages claims submissions to insurance providers for reimbursement. By integrating these services, Lemon Healthcare creates a smart healthcare ecosystem that simplifies the patient experience.

PeopleFund is Korea’s leading tech-based financial platform that is opening doors to financial freedom through affordable loans and attractive alternative investment products. It is the fastest growing marketplace lender in Korea and uniquely positioned as the first and only Korean marketplace lending platform to fully integrate with a top-tier commercial bank to process personal and business loans that are government approved. PeopleFund is also the first fintech platform to offer investment products directly on KakaoTalk, Korea’s most popular messaging app, which has allowed the company to grow and scale up its business. PeopleFund was founded in 2015 and is headquartered in Seoul, Korea.

Fount Inc., founded in 2015 and headquartered in Seoul, South Korea, operates as an asset management Robo-Advisor company. The firm offers Bluewhale, a Robo-Advisor engine that utilizes financial engineering technology and asset allocation theories to determine the optimal combination of assets for investors. Fount employs a proprietary investing algorithm based on Big Data technology, which assists clients in planning for various life events. The company emphasizes a passive investing strategy, aligning risk levels with clients' specific time horizons and allowing advanced algorithms to manage investments efficiently.